US-India trade agreement improves stocks, rupee outlook; GIFT Nifty up 4.5%

0

Indian equities are set to regain ground against Asian peers after India and the US finalized a long-awaited trade agreement. Early market indicators signal rising risk appetite, although challenges such as mixed earnings, valuation concerns, and uncertainty over future purchase commitments remain.

Indian equities are set to regain ground against Asian peers after India and the US finalized a long-awaited trade agreement. Early market indicators signal rising risk appetite, although challenges such as mixed earnings, valuation concerns, and uncertainty over future purchase commitments remain.

Indian equities are primed to narrow their rare underperformance versus Asian peers after New Delhi and Washington clinched a long-awaited trade agreement, removing a key overhang that had weighed on the nation’s financial assets and triggered record foreign outflows.

The accord, announced late Monday night India time, saw President Donald Trump cut the reciprocal tariff on Indian goods to 18% from 25% and eliminate an additional 25% duty linked to India’s purchases of Russian crude oil. The move is widely seen by fund managers as a catalyst for global investors to return to Indian equities, which logged their worst January since 2016, while also offering support to a rupee that has slid to a series of record lows.

“This is a good reset to India-US trade that may shift foreign investor sentiment toward India to positive,” said Arvind Chari, chief investment strategist at Q India UK. “India’s underperformance versus emerging markets could reverse.”

Market Mood

Early market reaction pointed to rising risk appetite. Nifty 50 futures traded at GIFT City surged as much as 4.5% overnight following the announcement, signaling optimism ahead of Tuesday’s session. Cash equities had shown tentative signs of a rebound earlier in the day, with the NSE Nifty 50 Index climbing 1.1% — its strongest gain in more than two months — even as most Asian markets closed in the red amid a broader regional selloff. The advance came despite investor concerns over a proposed tax hike on equity derivatives in the Feb. 1 budget and a sharp drop in metal prices that weighed on risk assets globally.

Valuation Reset

India’s valuation premium over Asia has also fallen to its lowest level in nearly five years as concerns about steep US tariffs and a drawn-out earnings slowdown weighed on sentiment. The trade deal’s finalization comes just a day after Sunday’s budget, which offered fresh support for exporters and strategic sectors such as rare earths, reinforcing early signs of improving investor confidence.

“It is a great development coming immediately after a path-breaking budget announcement that will lead to a reversal of foreign outflows and also rally in the Indian currency,” said A Balasubramanian, chief executive officer of Aditya Birla Sun Life AMC Ltd. “Close to $100 billion was waiting to enter into India over the next two to three years, pending the tariff settlement with the US.”

Lingering Risks

Still, not all of India’s challenges have eased. Earnings this reporting season have been mixed, and investors are awaiting clarity on India’s commitment to buy $500 billion of goods from the US as part of the deal. At the same time, scope for further monetary easing is narrowing, with economists in a Bloomberg survey expecting the central bank to hold rates on Feb. 6.

“The deal that US officials are outlining seems a relatively favorable one, although there will be questions as to whether the $500 billion in purchase commitments ever come to fruition,” said Michael Brown, senior research strategist at Pepperstone Group.

Growth Bets

For now, investors are looking past near-term uncertainties, drawing comfort from the finalization of the US-India trade deal and the budget’s growth tilt, which prioritized manufacturing incentives and infrastructure spending. Morgan Stanley expects stronger capital expenditure, services-sector growth and wider AI adoption to underpin earnings growth in the fiscal year beginning April 1.

“We remain constructive on Indian equities,” strategists including Ridham Desai wrote in a note before the US trade deal was announced, pointing to the prominence of semiconductors in the budget speech as a signal of long-term growth priorities.

More stories like this are available on bloomberg.com

Published on February 3, 2026

Access Denied

0

Access Denied You don’t have permission to access “http://hindi.gadgets360.com/electric-vehicle/tvs-motor-gets-first-rank-in-electric-two-wheeler-market-ola-electric-suffers-decline-in-sales-news-10934238” on this server.

Reference #18.bef93017.1774423154.4b6c8142

https://errors.edgesuite.net/18.bef93017.1774423154.4b6c8142

Precious metals plunge as Silver falls 10%, Gold down 6%

0

The precious metals complex continued its southward journey on Monday, but the movements in domestic and global markets were volatile as traders weighed in the latest hike in the CME Group margins for these metals.

Prospects of the US Fed turning hawkish and the dollar recovering, too, drove the complex lower. However, prices sashayed as some traders saw buying opportunities, though the bears seemed to have the upper hand currently.

In the morning, silver fell by over 10 per cent, gold by 7 per cent, platinum by 8 per cent and palladium by over 7 per cent as Friday’s hammering of the metals continued. But mid-day, the white precious metals pared its losses to 4 per cent and the yellow metal to 3.5 per cent. The palladium group metals (PGMs) edged up marginally.

Margin hike

The CME Group’s decision to hike the margins for gold futures from Monday to 8 per cent from 6 per cent and for silver to 15 per cent from 11 per cent unnerved investors. Platinum and palladium too will attract the same margin as silver.

Apurva Sheth, head of market perspective and research at Samco Securities, said from a price action perspective, the larger trend in gold remains clearly intact. The long-term structure continues to show higher highs and higher lows, and the recent decline looks more like a pause within an ongoing uptrend rather than the start of a reversal.

“What seems increasingly likely is a phase of time-wise consolidation. Gold may spend the next few months moving within a broad range, capped near ₹1,80,779 (per 10 gm) and supported around ₹1,36,185 and ₹1,32,294,” said Sheth.

common ranges

Such ranges are common after sharp advances, allowing excess optimism to cool off and positioning to reset, without damaging the underlying trend, said the Samco official.

Traders said investors are switching to bonds and currencies as they feel the new Fed Chief, Kevin Warsh, will likely increase interest rates, which will lead to the strengthening of the dollar. The dollar index was up 0.4 per cent at 97.285.

At 2000 hours IST, gold was lower at $4,738 an ounce, down 3 per cent from Friday’s close but up from $4,546.96 early in the morning. Gold April futures on COMEX recovered to $4,788.11 an ounce from $4,546.96 earlier in the day, though they are lower than Friday’s close.

In the Mumbai spot market, gold closed higher at ₹1,48, 748 per gm, up from ₹1,42,270 at open and a tad higher from Sunday’s close. On MCX, gold April futures recovered to ₹1,49,197 for gm from ₹1,40,424 in the morning and higher than Sunday’s closing prices.

Chinese premium

Silver recovered to $82.27 an ounce. Silver March futures ruled at $81.89 an ounce with the market swinging between $71.2 and $87.97. Spot gold prices in Mumbai closed at ₹2,59,500 a kg after having opened at ₹2,36.496. It was still lower than Sunday’s closing price of ₹2,65,751.

On MCX, silver March futures dropped by recovered to ₹2,54,492 a kg from ₹2,28,002 earlier in the day. On Sunday, they ended at ₹2,65,652. On the Shanghai futures market, silver dropped to 21,255 yuan a kg ($95.07 an ounce) with prices in China enjoying a premium owing to demand from multiple sectors.

Platinum slipped below $2,000 earlier in the day, but recovered to $2,138 an ounce, up nearly a per cent from Friday’s close., Palladium also recovered to $1,735 an ounce after dropping to $1,587, up 1.85 per cent from the previous trading close.

Still higher YTD

Despite the fall over the past two sessions, gold is up nearly 10 per cent since the beginning of the year, while silver’s gains have been shaved to 12.5 per cent. Platinum is up over 3 percent and palladium has increased by over 4 percent.

The precious metals complex has had a sparkling rally since January 2024, with gold soaring to a new high of $5,068 an ounce and silver to $122 an ounce, before they began to tumble.

Meanwhile, pointing to the COMEX report, traders said US multinational financial services firm, JP Morgan, closed its short positions in silver on Friday.

e.

More Like This

Market observers noted the correction appeared technical rather than structural.
NATHAN HOWARD

Published on February 2, 2026

Access Denied

0

Access Denied You don’t have permission to access “http://hindi.gadgets360.com/mobiles/india-becomes-huge-market-for-iphones-apple-gets-record-28-percent-in-value-share-news-10934071” on this server.

Reference #18.50200117.1774504074.2d901b34

https://errors.edgesuite.net/18.50200117.1774504074.2d901b34

Access Denied

0

Access Denied You don’t have permission to access “http://hindi.gadgets360.com/cryptocurrency/budget-offers-no-relief-for-taxation-on-crypto-segment-penalty-on-wrong-reporting-of-transactions-bitcoin-ethereum-news-10933787” on this server.

Reference #18.50200117.1774520406.2e2f454e

https://errors.edgesuite.net/18.50200117.1774520406.2e2f454e

Stocks to Watch: BSE, Angel One, Groww, Nuvama, 360 ONE WAM shares swing after STT hike

0

Shares of BSE climbed 4.5% to ₹2,694.50 on the NSE after touching an intraday low of ₹2,530, compared with the previous close of ₹2,578.10.

Shares of BSE climbed 4.5% to ₹2,694.50 on the NSE after touching an intraday low of ₹2,530, compared with the previous close of ₹2,578.10.

Shares of brokerage and exchange-linked companies saw sharp moves for the second straight session as investors digested the impact of the government’s decision to raise securities transaction tax (STT) on derivatives, with some counters rebounding after steep losses while others remained under pressure.

Shares of BSE climbed 4.5 per cent to ₹2,694.50 on the NSE after touching an intraday low of ₹2,530, compared with the previous close of ₹2,578.10.

Angel One also recovered, rising over 2 per cent to ₹2,371.90. In contrast, groww continued to trade in the red, slipping more than 4 per cent to ₹160.20. Nuvama Wealth, 360 ONE WAM and IIFL Capital Services remained volatile through the session.

Brokerages struck a cautious tone on the sector following the sharp hike in STT on futures and options. Motilal Oswal said it estimates FY27 earnings of Angel One, Groww and BSE to be hit by 13 per cent, 7 per cent and 9 per cent, respectively, assuming a 10 per cent impact on orders and volumes versus its current forecasts.

Elara Capital noted that a higher STT in the derivatives segment could reduce speculative churn and potentially attract long-term investors over time, but added that the budget was unlikely to immediately arrest foreign portfolio investor outflows. It said FPIs are still looking for signs of earnings recovery and stability in the rupee before committing fresh capital.

Emkay highlighted that while capital gains tax was largely left untouched, STT on derivatives was sharply raised to 5, 12.5 and 15 basis points on futures, option premia and option exercise, respectively, from 2, 1 and 1 basis point earlier. This, it said, could hurt volumes and market liquidity, even though retail participation has historically been resilient to such changes. Emkay added that exchanges and broking firms are the primary near-term losers, and warned that lower market depth could eventually weigh on overseas institutional flows.

Jefferies described the move as a sentimentally negative development for the sector. Based on discussions with industry participants, the brokerage projected a volume impact of up to 5 per cent. It said it expects a similar decline in average daily turnover or orders for BSE and Groww, which could translate into about a 4 per cent hit to earnings.

Bernstein focused on the potential fallout for high-frequency trading firms, which form a key client base for Nuvama Wealth’s services business. The brokerage said that if higher STT meaningfully erodes profit spreads for such traders, it could shrink the overall profit pool in Indian markets and hurt Nuvama in turn. It added that market-neutral strategies could face a greater impact compared with directional trades.

Kotak Institutional Equities said the sharp STT hike in the F&O segment came as a surprise, particularly in futures, which it termed a bit unreasonable given the higher level of institutional participation. While it believes the increase in options STT may be less disruptive as volumes there are driven more by accessibility, Kotak argued that a reduction in STT on cash equities would have been more effective in addressing the disproportionate share of derivatives trading. For retail brokers, the firm said January volumes had been strong but advised waiting for clearer trends to emerge, especially after recent commodity price corrections.

Citi, meanwhile, said Angel One and Groww could face marginal topline pressure due to their higher dependence on F&O revenues, while the impact on other capital market players such as Nuvama is likely to be limited. Overall, analysts suggested that while the immediate reaction in stocks has been volatile, the trajectory of trading volumes in coming weeks will be key to determining how sharply earnings estimates across the sector are revised.

Published on February 2, 2026

Q3 Results Today Highlights: Bajaj Housing, Hyundai Motor & Sundaram Finance, PB Fintech profit rise, UPL, Honeywell Automation Q3 profit falls, Ather Q3 loss narrows, Tata Chemicals Q3 loss widens

0

02-Feb-2026

derivatives

• Indus Towers Ltd

• PG Electroplast Ltd

• UPL Ltd

• PB Fintech Ltd

Cash Segment

• Thermax Ltd

• Bajaj Housing Fin Ltd

• Honeywell Automation India Ltd

• Akzo Nobel India Ltd

• Aarti Industries Ltd

• Ather Energy Ltd

• Campus Activewear Ltd

• City Union Bank Ltd

• Paradeep Phosphates Ltd

• Tata Chem Ltd

• Chateau Hotels Ltd

• Hyundai Motor India Ltd

• Railtel Corp Of India Ltd

• Aditya Birla Lifestyle Brands Ltd

• Olectra Greentech Ltd

03-Feb-2026

derivatives

• Bajaj Fin Ltd

• Mankind Pharma Ltd

• Pidilite Ind Ltd

• Adani Ports and Special Eco Zone Ltd

• Aditya Birla Capital Ltd

• Adani Enterprises Ltd

• Solar Ind India Ltd

• Varun Beverages Ltd

• NMDC Ltd.

Cash Segment

• Castrol India Ltd

• Godrej Agrovet Ltd

• Alkyl Amines Chem Ltd

• Action Construction Equipment Ltd

• Aether Industries Ltd

• Firstsource Solutions Ltd

• Gabriel India Ltd

• HFCL Ltd

• PCBL Chem Ltd

• Signatureglobal (India) Ltd

• Triveni Turbine Ltd

• Zydus Wellness Ltd

• AWL Agri Business Ltd

• Choice Intl Ltd

• Dr. Agarwal’s Health Care Ltd

• JK Lakshmi Cement Ltd

• Sheela Foam Ltd

• Lloyds Metals & Energy Ltd

• NMDC Steel Ltd

04-Feb-2026

derivatives

• NHPC Ltd.

• Bajaj Finserv Ltd

• Bajaj Holdings & Inv Ltd

• Cummins India Ltd

• Tata Power Co Ltd

• Trent Ltd

• Tube Invs of India Ltd

• Sammaan Capital Ltd

Cash Segment

• Emami Ltd

• Aptus Value Housing Fin India Ltd

• Timken India Ltd

• Gallantt Ispat Ltd

• Hexaware Tech Ltd

• Jubilant Ingrevia Ltd

• Apollo Tires Ltd

• CCL Products (India) Ltd

• Cera Sanitaryware Ltd

• Emcure Pharma Ltd

• Global Health Ltd

• Rites Ltd

• Inventurus Knowledge Solutions Ltd

• Jaiprakash Power Ventures Ltd

• Kalpataru Projects Intl Ltd

• Force Motors Ltd

• Redington Ltd

• Metropolis Healthcare Ltd

05-Feb-2026

derivatives

• Tata Motors Passenger Vehicles Ltd

• Godrej Properties Ltd

• Indian Oil Corp Ltd

• Page Ind Ltd

• Bharti Airtel Ltd

• FSN E-Commerce Ventures Ltd

• Hero MotoCorp Ltd

• Hitachi Energy India Ltd

• Kaynes Technology India Ltd

• Life Ins Corp Of India

• UNO Minda Ltd

• Power Fin Corp Ltd

• Rail Vikas Nigam Ltd

• Suzlon Energy Ltd

• Astral Ltd

• Max Healthcare Institute Ltd

Cash Segment

• Berger Paints India Ltd

• JM Fin Ltd

• Cemindia Projects Ltd

• Alembic Pharma Ltd

• NCC Ltd

• Aavas Financiers Ltd

• Bharti Hexacom Ltd

• Caplin Point Laboratories Ltd

• Minda Corp Ltd

• Sai Life Sciences Ltd

• Nava Ltd

• Aditya Birla Fashion and Retail Ltd

• Hindustan Copper Ltd

• Data Patterns (India) Ltd

• Kirloskar Brothers Ltd

• Poly Medicure Ltd

• PVR Inox Ltd

06-Feb-2026

derivatives

• Bosch Ltd

• SHREE CEMENT LTD

• Kalyan Jewelers India Ltd

• Crompton Greaves Cons Electricals Ltd

• Tata Steel Ltd

Cash Segment

• Godawari Power And Ispat Ltd

• Jubilant Pharmova Ltd

• MRF Ltd

• Swan Corp Ltd

• BEML Ltd.

• CESC Ltd.

• Sapphire Foods India Ltd

• Sonata Software Ltd

• Sun TV Network Ltd

• Whirlpool Of India Ltd

• Lemon Tree Hotels Ltd

07-Feb-2026

derivatives

• State Bank of India

Cash Segment

• HBL Engineering Ltd

• Sarda Energy & Minerals Ltd

• Mahanagar Gas Ltd

• General Ins Corp of India

09-Feb-2026

derivatives

• BSE Ltd

• Zydus Lifesciences Ltd

• Aurobindo Pharma Ltd

Cash Segment

• Navin Fluorine Intl Ltd

• Glaxosmithkline Pharma Ltd

• Cholamandalam Fin Holdings Ltd

• Gujarat State Fertilizer…

Biopharma SHAKTI: Stocks in focus after Budget 2026

0

The Budget announcement included a ₹10,000 crore outlay to develop biopharmaceutical production in India. Over the next five years biopharmaceutical focus is to be developed in educational institutions through NIPERS (National Institute of Pharmaceutical Education and Research) and even regulatory arm – CDSCO (Central Drugs Standard Control Organisation). The plan also includes developing over 1,000 clinical trial sites. As the speech noted Indian pharmaceuticals need to align with the noncommunicable disease burden which has overtaken communicable diseases as the cause for deaths in India. Globally as well, small molecules (chemically synthesized) are ceding space to biologics/biosimilars.

Company focus

Indian companies have been focusing on biologics/biosimilar production. Biocon has the largest concentration of biopharmaceutical products in its revenues with more than 60 per cent of H1FY26 revenues from biologics and biosimilars. The other companies have a basket of developed and commercialized biosimilars – Sun Pharma, Dr. Reddy and Zydus Lifesceices. The other leading pharma companies, including Aurobindo and Cipla are in a development mode with respect to biosimilars.

The announcement also mentioned an improved approval timeframe for biosimilars and large network of clinical testing sites. These two measures along with a larger talent pool of professionals should drive Indian companies shift from a small molecule led portfolio to a biologics/biosimilar led portfolio.

Published on February 1, 2026

Access Denied

0

Access Denied You don’t have permission to access “http://hindi.gadgets360.com/mobiles/samsung-galaxy-s26-may-get-exynos-2600-chipset-listed-on-geekbench-news-10933249” on this server.

Reference #18.50200117.1774523995.2e69482d

https://errors.edgesuite.net/18.50200117.1774523995.2e69482d

Gokaldas Exports Q3 profit plunges 71% as US tariffs weigh on earnings

0

Sivaramakrishnan Ganapati, Vice-Chairman and Managing Director, Gokaldas Exports

Sivaramakrishnan Ganapati, Vice-Chairman and Managing Director, Gokaldas Exports | Photo Credit:

Shares of Gokaldas Exports fell nearly 4.92 per cent in Monday’s trade after the company reported a sharp 71 per cent year-on-year decline in profit after tax (PAT) for Q3FY26. Addressing investors after the results, Vice-Chairman and Managing Director Sivaramakrishnan Ganapati said the company’s performance during the quarter was significantly impacted by steep US tariffs, resulting in an estimated impact of around ₹40 crore.

He added that US-based brands are increasingly hesitant to build inventory at higher tariff levels, and may be factoring in weaker consumer demand in 2026. In contrast, imports from the EU and the UK recorded higher growth in the January–November 2025 period than in the same period last year. Looking ahead, Ganapati said the company has good visibility on its order book for both its India and Africa operations in the coming quarters.

Margin pressure

On margins, he cautioned that the reciprocal tariffs imposed by the US on India are likely to continue impacting performance in the next quarter as well. “Any positive outcome from a US-India trade agreement will, of course, help offset this impact,” he said, adding that the Africa business is beginning to see some tailwinds.

Africa operations

The company’s Africa operations, however, were impacted in Q3 by the expiry of the African Growth and Opportunity Act (AGOA), which led to a dip in orders and revenues from the region. This was compounded by supply chain disruptions that affected operations in the quarter. Ganapati noted that the imposition of incremental reciprocal tariffs on Asian countries from August 2025 has since restored Africa’s relative tariff advantage.

Margin recovery

From Q4 onwards, the company expects margin improvement in its Africa business, supported by a stronger order book. This improvement is driven by higher reciprocal tariffs of up to 20 per cent on Asian countries, while tariffs on African exports remain at around 10 per cent.

Over the longer term, Ganapati said free trade agreements with the EU and the UK are expected to provide structural benefits. “Until those materialise, we expect a degree of status quo, with improvements largely coming from internal efficiency measures,” he said.

bangladesh watch

Providing an update on Bangladesh, Ganapati said the company continues to utilize subcontracting relationships in the country. However, any direct investment in Bangladesh would be considered only after greater clarity emerges on the macroeconomic situation.

“There is an election expected in February, and we will take a call after assessing how the situation evolves post that,” he said.

Published on February 2, 2026